Literature DB >> 12860318

Antimalarial activity of Cinchona-like plants used to treat fever and malaria in Brazil.

V F Andrade-Neto1, M G L Brandão, J R Stehmann, L A Oliveira, A U Krettli.   

Abstract

For centuries, malaria was treated with the bark of Cinchona calisaya and Cinchona succirubra plants named "quinas" in Brazil, from which the quinine molecule was isolated. Other plant species known also as "quinas" are used to treat fever and malaria, like Deianira erubescens (roots and leaves), Strychnos pseudoquina (bark), and Remijia ferruginea (bark). Based on this popular knowledge, we evaluated the in vivo antimalarial activity of the ethanol crude extracts of these plant species in mice infected with Plasmodium berghei. Only Remijia ferruginea showed antimalarial activity, reducing parasitaemia and mortality at the highest dose tested. Its phytochemical analysis showed the presence of alkaloids but not quinine. The other two plant species were inactive.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12860318     DOI: 10.1016/s0378-8741(03)00141-7

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  20 in total

1.  In-vivo antimalarial activity of aqueous leaf and bark extracts of Trema orientalis against Plasmodium berghei in mice.

Authors:  Oluwatoyosi Eniola Oyebola; Olajumoke Abimbola Morenikeji; Isaiah Oluwafemi Ademola
Journal:  J Parasit Dis       Date:  2016-07-07

2.  In vivo antimalarial activity of Trichilia megalantha harms extracts and fractions in animal models.

Authors:  Dorcas A Fadare; Oyindamola O Abiodun; Edith O Ajaiyeoba
Journal:  Parasitol Res       Date:  2013-06-26       Impact factor: 2.289

3.  In vitro and in vivo anti-malarial activity of Boerhavia elegans and Solanum surattense.

Authors:  Ali Ramazani; Sedigheh Zakeri; Soroush Sardari; Nastaran Khodakarim; Navid Dinparas Djadidt
Journal:  Malar J       Date:  2010-05-12       Impact factor: 2.979

4.  Assessment of in vivo antimalarial activities of some selected medicinal plants from Turkey.

Authors:  Ahmet Ozbilgin; Cenk Durmuskahya; Husniye Kayalar; Ipek Ostan
Journal:  Parasitol Res       Date:  2013-10-22       Impact factor: 2.289

5.  Synthesis, antimalarial activity, and intracellular targets of MEFAS, a new hybrid compound derived from mefloquine and artesunate.

Authors:  Fernando de Pilla Varotti; Ana Cristina C Botelho; Anderson Assunção Andrade; Renata C de Paula; Elaine M S Fagundes; Alessandra Valverde; Lúcia M U Mayer; Jorge Souza Mendonça; Marcus V N de Souza; Núbia Boechat; Antoniana Ursine Krettli
Journal:  Antimicrob Agents Chemother       Date:  2008-08-18       Impact factor: 5.191

6.  Antileishmanial activity and evaluation of the mechanism of action of strychnobiflavone flavonoid isolated from Strychnos pseudoquina against Leishmania infantum.

Authors:  Paula S Lage; Miguel A Chávez-Fumagalli; Juliana T Mesquita; Laís M Mata; Simone O A Fernandes; Valbert N Cardoso; Manuel Soto; Carlos A P Tavares; João P V Leite; Andre G Tempone; Eduardo A F Coelho
Journal:  Parasitol Res       Date:  2015-09-07       Impact factor: 2.289

7.  Ethnopharmacology of medicinal plants of the pantanal region (mato grosso, Brazil).

Authors:  Isanete Geraldini Costa Bieski; Fabrício Rios Santos; Rafael Melo de Oliveira; Mariano Martinez Espinosa; Miramy Macedo; Ulysses Paulino Albuquerque; Domingos Tabajara de Oliveira Martins
Journal:  Evid Based Complement Alternat Med       Date:  2012-02-26       Impact factor: 2.629

Review 8.  Malaria in South America: a drug discovery perspective.

Authors:  Luiza R Cruz; Thomas Spangenberg; Marcus V G Lacerda; Timothy N C Wells
Journal:  Malar J       Date:  2013-05-24       Impact factor: 2.979

9.  Plants used traditionally to treat malaria in Brazil: the archives of Flora Medicinal.

Authors:  Alexandros S Botsaris
Journal:  J Ethnobiol Ethnomed       Date:  2007-05-01       Impact factor: 2.733

10.  Is 'mainstreaming AYUSH' the right policy for Meghalaya, northeast India?

Authors:  Sandra Albert; John Porter
Journal:  BMC Complement Altern Med       Date:  2015-08-18       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.